BBOT Competitors & Alternatives
Compare BridgeBio Oncology Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
BBOT
Main Stock$7.74
Tradestie Score
50
Market Cap
$952.74M
Analyst Upside
+224.6%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.82
|
$665.30M | - | 49 | Compare |
|
ANL
ANL
|
$10.51
|
$656.86M | - | 51 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$13.96
|
$626.91M | - | 54 | Compare |
|
SVRA
Savara Inc.
|
$5.46
|
$611.84M | - | 60 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.05
|
$552.46M | - | 50 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.25
|
$540.97M | - | 61 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$12.57
|
$529.35M | 6.5 | 62 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.95
|
$512.39M | - | 51 | Compare |
More BBOT Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry